101 related articles for article (PubMed ID: 26860867)
21. Antigenic properties of the human immunodeficiency virus envelope during cell-cell fusion.
Finnegan CM; Berg W; Lewis GK; DeVico AL
J Virol; 2001 Nov; 75(22):11096-105. PubMed ID: 11602749
[TBL] [Abstract][Full Text] [Related]
22. P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.
Giroud C; Marin M; Hammonds J; Spearman P; Melikyan GB
J Virol; 2015 Sep; 89(18):9368-82. PubMed ID: 26136569
[TBL] [Abstract][Full Text] [Related]
23. Adaptive mutations in the V3 loop of gp120 enhance fusogenicity of human immunodeficiency virus type 1 and enable use of a CCR5 coreceptor that lacks the amino-terminal sulfated region.
Platt EJ; Kuhmann SE; Rose PP; Kabat D
J Virol; 2001 Dec; 75(24):12266-78. PubMed ID: 11711617
[TBL] [Abstract][Full Text] [Related]
24. HIV and SIV gp120 binding does not predict coreceptor function.
Baik SS; Doms RW; Doranz BJ
Virology; 1999 Jul; 259(2):267-73. PubMed ID: 10388651
[TBL] [Abstract][Full Text] [Related]
25. In a human lymphomyeloid progenitor cell line (KG-1) HIV-1 gp120 binds to chemokine-receptors CXC-R4 and CCR5, only in the presence of CD4.
Re MC; Vignoli M; Furlini G; Ramazzotti E; Maldini C; La Placa M
New Microbiol; 1999 Oct; 22(4):365-8. PubMed ID: 10555208
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
27. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
[TBL] [Abstract][Full Text] [Related]
28. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
29. Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.
Harada T; Tatsumi M; Takahashi H; Sata T; Kurata T; Kojima A
Microbes Infect; 2004 Apr; 6(5):421-8. PubMed ID: 15109956
[TBL] [Abstract][Full Text] [Related]
30. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
31. CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.
Singer II; Scott S; Kawka DW; Chin J; Daugherty BL; DeMartino JA; DiSalvo J; Gould SL; Lineberger JE; Malkowitz L; Miller MD; Mitnaul L; Siciliano SJ; Staruch MJ; Williams HR; Zweerink HJ; Springer MS
J Virol; 2001 Apr; 75(8):3779-90. PubMed ID: 11264367
[TBL] [Abstract][Full Text] [Related]
32. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
33. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
34. Tree Shrew Cells Transduced with Human CD4 and CCR5 Support Early Steps of HIV-1 Replication, but Viral Infectivity Is Restricted by APOBEC3.
Luo MT; Mu D; Yang X; Luo RH; Zheng HY; Chen M; Guo YQ; Zheng YT
J Virol; 2021 Jul; 95(16):e0002021. PubMed ID: 34076481
[TBL] [Abstract][Full Text] [Related]
35. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.
Swartz TH; Esposito AM; Durham ND; Hartmann BM; Chen BK
J Virol; 2014 Oct; 88(19):11504-15. PubMed ID: 25031337
[TBL] [Abstract][Full Text] [Related]
36. [Replication inhibitors targeting early events in the HIV-1 life cycle].
Ichiyama K; Yamamoto N
Nihon Rinsho; 2002 Apr; 60(4):784-9. PubMed ID: 11968789
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of HIV-1-mediated syncytium formation and virus replication by the lipophosphoglycan from Leishmania donovani is due to an effect on early events in the virus life cycle.
Genois N; Barbeau B; Olivier M; Tremblay MJ
Clin Exp Immunol; 2001 Apr; 124(1):32-42. PubMed ID: 11359440
[TBL] [Abstract][Full Text] [Related]
38. The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
Fischer PB; Collin M; Karlsson GB; James W; Butters TD; Davis SJ; Gordon S; Dwek RA; Platt FM
J Virol; 1995 Sep; 69(9):5791-7. PubMed ID: 7543588
[TBL] [Abstract][Full Text] [Related]
39. Dual role of novel ingenol derivatives from Euphorbia tirucalli in HIV replication: inhibition of de novo infection and activation of viral LTR.
Abreu CM; Price SL; Shirk EN; Cunha RD; Pianowski LF; Clements JE; Tanuri A; Gama L
PLoS One; 2014; 9(5):e97257. PubMed ID: 24827152
[TBL] [Abstract][Full Text] [Related]
40. Chemically induced infection of CD4-negative HeLa cells with HIV-1.
Harada S; Maeda Y
Microbiol Immunol; 1999; 43(12):1077-86. PubMed ID: 10656175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]